Exelan Pharmaceuticals Inc., Boca Raton, Florida, has been awarded a maximum $8,748,919 modification (P00005) exercising the third one-year option period of a one-year base contract (SPE2D2-19-D-0070) with four one-year option periods for finasteride tablets. This is a fixed-price, requirements contract. Location of performance is New York, with a May 28, 2023, performance completion date. Using customers are Defense Department, Department of Veterans Affairs, Indian Health Service and Federal Bureau of Prisons. Type of appropriation is fiscal 2022 through 2023 defense working capital funds. The contracting agency is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.
Recommended
free preview